Side effects across medicines
Medicines whose labels list tingling
663 medicines have an FDA label that names tingling (paresthesia) in its boxed warning, warnings, adverse reactions, trial table, patient leaflet or Drug Facts “stop use” warning (of the labels PlainMeds reads: each medicine's quoted label and up to eight more, by route and wording). Among them, the most FAERS reports of tingling name adalimumab (7,590), trisodium citrate (5,693) and etanercept (5,507), through July 30, 2026. A label lists what its studies and reports found, and a report does not show that a medicine caused the event.
Check it at the source: the FDA FAERS public dashboard; FDA labels on DailyMed.
Which medicines' labels list tingling?
Ordered by where the label names it, the boxed warning first, then by FAERS reports. The first 150 of the 663 are below; every other one is on its medicine record. A medicine whose own indications name it, because it treats it, is not counted.
| Medicine | Where a label names it | FAERS reports of tingling |
|---|---|---|
| Ciprofloxacin | warnings and precautions (intravenous label) | 2,697 |
| Metronidazole | warnings and precautions (vaginal label) | 1,144 |
| Levofloxacin | warnings and precautions (intravenous label) | 841 |
| Sumatriptan | warnings and precautions (nasal label) | 797 |
| Moxifloxacin | warnings and precautions (intravenous label) | 400 |
| Tacrolimus | warnings and precautions (intravenous/ | 392 |
| Benzonatate | precautions | 127 |
| Ofloxacin | warnings (oral label) | 122 |
| Acetazolamide | precautions | 119 |
| Labetalol | precautions (intravenous label) | 91 |
| Ethacrynic acid | precautions | none in the top 1,000 |
| Foscarnet | precautions | none in the top 1,000 |
| Hydralazine | precautions | none in the top 1,000 |
| Nefazodone | precautions | none in the top 1,000 |
| Onasemnogene abeparvovec | warnings and precautions (intrathecal label) | none in the top 1,000 |
| Procarbazine | precautions | none in the top 1,000 |
| Adalimumab | adverse reactions | 7,590 |
| Trisodium citrate | adverse reactions (intravenous label) | 5,693 |
| Etanercept | adverse reactions | 5,507 |
| Omeprazole | adverse reactions | 5,236 |
| Pregabalin | adverse reactions | 4,873 |
| Lisinopril | adverse reactions | 4,247 |
| Simvastatin | adverse reactions | 3,116 |
| Diclofenac | adverse reactions (oral label) | 3,015 |
| Lenalidomide | adverse reactions | 2,987 |
| Rituximab | adverse reactions | 2,940 |
| Topiramate | adverse reactions | 2,871 |
| Furosemide | adverse reactions | 2,842 |
| Amlodipine | adverse reactions | 2,819 |
| Teriflunomide | adverse reactions | 2,814 |
| Diphenhydramine | adverse reactions | 2,813 |
| Metoprolol | adverse reactions | 2,791 |
| Venlafaxine | adverse reactions | 2,651 |
| Dexamethasone | adverse reactions (intramuscular/ | 2,644 |
| Celecoxib | adverse reactions | 2,588 |
| Tofacitinib | adverse reactions | 2,457 |
| Ramipril | adverse reactions | 2,447 |
| Clonazepam | adverse reactions | 2,309 |
| Quetiapine | adverse reactions | 2,220 |
| Methylprednisolone | adverse reactions (intramuscular/ | 2,125 |
| Hydrochlorothiazide | adverse reactions | 2,033 |
| Losartan | adverse reactions | 1,949 |
| Escitalopram | adverse reactions | 1,891 |
| Lamotrigine | adverse reactions | 1,872 |
| Citalopram | adverse reactions | 1,820 |
| Dalfampridine | adverse reactions | 1,805 |
| Baclofen | adverse reactions | 1,750 |
| Zolpidem | adverse reactions | 1,730 |
| Oxaliplatin | adverse reactions | 1,608 |
| Montelukast | adverse reactions | 1,581 |
| Capecitabine | adverse reactions | 1,546 |
| Bupropion | adverse reactions | 1,384 |
| Adalimumab-fkjp | adverse reactions | 1,347 |
| Adalimumab-aaty | adverse reactions | 1,345 |
| Ondansetron | adverse reactions (intramuscular/ | 1,317 |
| Carvedilol | adverse reactions | 1,240 |
| Glatiramer | adverse reactions | 1,173 |
| Allopurinol | adverse reactions | 1,134 |
| Estradiol | adverse reactions (transdermal label) | 1,123 |
| Mirtazapine | adverse reactions | 1,103 |
| Duloxetine | adverse reactions | 1,097 |
| Bisoprolol | adverse reactions | 1,082 |
| Potassium chloride | adverse reactions (intravenous label) | 1,081 |
| Acyclovir | adverse reactions | 1,078 |
| Paclitaxel | adverse reactions | 1,033 |
| Mycophenolate mofetil | adverse reactions | 1,030 |
| Buprenorphine | adverse reactions (transdermal label) | 1,015 |
| Propranolol | adverse reactions | 993 |
| Ezetimibe | adverse reactions | 987 |
| Tramadol | adverse reactions | 984 |
| Cyclobenzaprine | adverse reactions | 972 |
| Paroxetine | adverse reactions | 972 |
| Carboplatin | adverse reactions | 947 |
| Cyclophosphamide | adverse reactions | 889 |
| Bortezomib | adverse reactions | 862 |
| Trastuzumab | adverse reactions | 837 |
| Letrozole | adverse reactions | 772 |
| Sodium oxybate | adverse reactions | 763 |
| Atomoxetine | adverse reactions | 745 |
| Chlorhexidine | adverse reactions (dental label) | 727 |
| Tiotropium | adverse reactions | 705 |
| Carbamazepine | adverse reactions | 687 |
| Sildenafil | adverse reactions | 685 |
| Cyanocobalamin | adverse reactions (nasal label) | 675 |
| Fentanyl | adverse reactions (transdermal label) | 665 |
| Treprostinil | adverse reactions | 630 |
| Diltiazem | adverse reactions | 628 |
| Cyclosporine | adverse reactions | 625 |
| Hydromorphone | adverse reactions | 616 |
| Epinephrine and lidocaine | adverse reactions (submucosal label) | 613 |
| Mometasone | adverse reactions (topical label) | 605 |
| Modafinil | adverse reactions | 603 |
| Anastrozole | adverse reactions | 596 |
| Tadalafil | adverse reactions | 584 |
| Epinephrine | adverse reactions | 573 |
| Golimumab | adverse reactions | 563 |
| Azithromycin | adverse reactions | 558 |
| Enalapril | adverse reactions | 557 |
| Ciprofloxacin and hydrocortisone | adverse reactions | 553 |
| Fluconazole | adverse reactions | 553 |
| Morphine | adverse reactions | 552 |
| Enzalutamide | adverse reactions | 550 |
| Etonogestrel | adverse reactions | 544 |
| Olanzapine | adverse reactions | 544 |
| Phenylephrine | adverse reactions | 544 |
| Zoledronic acid | adverse reactions | 529 |
| Nitroglycerin | adverse reactions | 511 |
| Clonidine | adverse reactions | 507 |
| Fluticasone and salmeterol | adverse reactions | 481 |
| Minocycline | adverse reactions | 461 |
| Leuprolide | adverse reactions | 453 |
| Thalidomide | adverse reactions | 423 |
| Tizanidine | adverse reactions | 412 |
| Pertuzumab | adverse reactions | 408 |
| Tretinoin | adverse reactions (oral label) | 394 |
| Divalproex | adverse reactions | 381 |
| Nebivolol | adverse reactions | 379 |
| Alemtuzumab | adverse reactions | 378 |
| Nifedipine | adverse reactions | 376 |
| Fulvestrant | adverse reactions | 372 |
| Lisdexamfetamine | adverse reactions | 363 |
| Exemestane | adverse reactions | 334 |
| Armodafinil | adverse reactions | 330 |
| Clarithromycin | adverse reactions | 330 |
| Amifampridine | adverse reactions | 327 |
| Lovastatin | adverse reactions | 327 |
| Piroxicam | adverse reactions | 325 |
| Phentermine and topiramate | adverse reactions | 323 |
| Gemcitabine | adverse reactions | 317 |
| Cinacalcet | adverse reactions | 315 |
| Progesterone | adverse reactions | 315 |
| Amitriptyline | adverse reactions | 308 |
| Dexlansoprazole | adverse reactions | 306 |
| Dichlorphenamide | adverse reactions | 303 |
| Iron sucrose | adverse reactions | 299 |
| Vilazodone | adverse reactions | 295 |
| Acetaminophen and oxycodone | adverse reactions | 290 |
| Carbidopa and levodopa | adverse reactions | 274 |
| Gadobenate | adverse reactions | 263 |
| Trazodone | adverse reactions | 255 |
| Ezetimibe and simvastatin | adverse reactions | 254 |
| Everolimus | adverse reactions | 247 |
| Eculizumab | adverse reactions | 243 |
| Eszopiclone | adverse reactions | 243 |
| Rizatriptan | adverse reactions | 239 |
| Gadodiamide | adverse reactions | 228 |
| Indomethacin | adverse reactions | 228 |
| Testosterone | adverse reactions | 228 |
| Torsemide | adverse reactions | 228 |
| Human immunoglobulin g | adverse reactions | 216 |
Source: FDA drug labels via openFDA, read October 8, 2026; FAERS via openFDA, reports through July 30, 2026
Which of them have the most tingling reports in FAERS?
Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026; MedDRA preferred term “Paraesthesia”
What next?
- Side effects across medicines
- every reaction on PlainMeds
- Report a side effect to the FDA
- MedWatch